Doctor profile · Federal record

Dr. Joshua McFarlane, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Richmond, VA

  • NPI 1184847055
  • Accepts Medicare
  • MIPS 74.6 / 100 · 2023
  • 23 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
8007 Discovery Dr Ste A
Richmond, VA 232298605
(804) 287-3000
fax (804) 673-2731
Additional location
6605 W Broad St, Credentialing Suite A
Richmond, VA 232301714
Mailing address
7202 Glen Forest Dr, Credentialing Suite 200
Richmond, VA 232263781

Credentials & registration

NPPES · NUCC
NPI registered
April 2007 — 19 yrs on file
Profile last updated
March 17, 2022
Year of graduation
2003 — 23 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State licenses (2)
Virginia #0101245050 · Tennessee #390200000X

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1184847055. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
91,465
Distinct HCPCS
10
Medicare allowed
$1,909,614
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 41,310 69 $1
J9271 Injection, pembrolizumab, 1 mg 13,000 27 $54
J9299 Injection, nivolumab, 1 mg 8,760 14 $30
J0897 Injection, denosumab, 1 mg 7,980 46 $23
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 5,760 13 $47
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 2,490 16 $45
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 2,410 35 $7
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,536 87 $0
J9041 Injection, bortezomib, 0.1 mg 1,155 11 $5
J0461 Injection, atropine sulfate, 0.01 mg 800 11 $0

In context: peer comparison

Among 20 peers in Richmond Hematology & Oncology Physician, average services per provider: 1,385. This provider delivers 66× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,040
Transactions
73
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals Lp 12 $334.26
Novartis Pharmaceuticals Corporation 15 $315.03
Pfizer INC. 11 $184.59
Ipsen Biopharmaceuticals, INC 5 $109.88
Janssen Biotech, INC. 5 $87.72
E.R. Squibb & Sons, L.L.C. 5 $80.71
Merck Sharp & Dohme LLC 3 $60.91
Puma Biotechnology, INC. 3 $60.41
Takeda Pharmaceuticals U.S.A., INC. 2 $57.73
Eisai INC. 2 $55.01
Bayer Healthcare Pharmaceuticals INC. 2 $52.61
Taiho Oncology, INC. 2 $49.64
Lilly USA, LLC 2 $49.35
Celgene Corporation 2 $40.91
Genmab U.S., INC. 2 $37.38

By nature of payment

Food and Beverage
$2,040

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
919
Patients
205
Total drug cost
$944,243
Drug Type Claims Patients Total cost
Eliquis (Apixaban) Brand 117 22 $83,206
Oxycodone Hcl Generic 114 28 $5,085
Hydroxyurea Generic 102 22 $2,990
Prednisone Generic 86 25 $1,383
Dexamethasone Generic 83 22 $1,349
Ondansetron Hcl Generic 53 32 $1,323
Tramadol Hcl Generic 50 13 $508
Levothyroxine Sodium Generic 47 11 $617
Xarelto (Rivaroxaban) Brand 46 11 $40,380
Letrozole Generic 42 0 $2,957

Frequently asked questions

Auto-generated from federal data
What is Dr. Joshua McFarlane's medical specialty?
Dr. Joshua McFarlane practices Hematology & Oncology Physician in Richmond, VA.
Where does Dr. Joshua McFarlane practice?
Dr. Joshua McFarlane practices at 8007 Discovery Dr Ste A, Richmond, VA 232298605. Office phone: 8042873000.
What is Dr. Joshua McFarlane's NPI?
Dr. Joshua McFarlane's National Provider Identifier (NPI) is 1184847055, issued by NPPES.
Does Dr. Joshua McFarlane accept Medicare assignment?
Yes. Dr. Joshua McFarlane accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Joshua McFarlane commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, nivolumab, 1 mg (HCPCS J9299). Source: CMS Medicare Physician & Other Practitioners file.